Stock GNPX GENPREX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Genprex, Inc.

Equities

GNPX

US3724462037

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
2.12 USD -4.07% Intraday chart for Genprex, Inc. -4.48% -76.96%
Apr. 03 Genprex Expands Clinical Trial Sites for Acclaim-3 Clinical Study of Reqorsa Therapy in Combination with Tecentriq to Treat Small Cell Lung Cancer CI
Apr. 02 Genprex, Inc. Collaborators Publish Positive Preclinical Data with NPRL2 Gene Therapy Utilizing Oncoprex® Delivery System CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
HC Wainwright Initiates Genprex With Buy Rating, $10 Price Target
MT
Dawson James Initiates Genprex at Buy Rating With $3 Price Target
MT
GENPREX : National Securities Starts Genprex at Buy With $7 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GNPX Stock
  4. News Genprex, Inc.
  5. Analyst Reco.